Dysphonia
-
Fibrocell Shares Plummet Following Disappointing Clinical Study
Exton based Fibrocell Science saw over a third of its share value disappear on Wednesday, after it announced disappointing results from the second-stage clinical trial on…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
